title: Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c.
abstract: Although red blood cell (RBC) life span is a known determinant of percentage hemoglobin A1c (HbA1c), its variation has been considered insufficient to affect clinical decisions in hematologically normal persons. However, an unexplained discordance between HbA1c and other measures of glycemic control can be observed that could be, in part, the result of differences in RBC life span. To explore the hypothesis that variation in RBC life span could alter measured HbA1c sufficiently to explain some of this discordance, we determined RBC life span using a biotin label in 6 people with diabetes and 6 nondiabetic controls. Mean RBC age was calculated from the RBC survival curve for all circulating RBCs and for labeled RBCs at multiple time points as they aged. In addition, HbA1c in magnetically isolated labeled RBCs and in isolated transferrin receptor-positivereticulocytes was used to determine the in vivo synthetic rate of HbA1c. The mean age of circulating RBCs ranged from 39 to 56 days in diabetic subjects and 38 to 60 days in nondiabetic controls. HbA1c synthesis was linear and correlated with mean whole blood HbA1c (R(2) = 0.91). The observed variation in RBC survival was large enough to cause clinically important differences in HbA1c for a given mean blood glucose.
authors.affiliation: Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, University of Cincinnati College of Medicine, Vontz Center for Molecular Studies, 3125 Eden Avenue, Cincinnati, OH 45267-0547, USA. robert.cohen@uc.edu
authors.forename: Robert M
authors.initials: RM
authors.lastname: Cohen
authors.forename: Robert S
authors.initials: RS
authors.lastname: Franco
authors.forename: Paramjit K
authors.initials: PK
authors.lastname: Khera
authors.forename: Eric P
authors.initials: EP
authors.lastname: Smith
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Lindsell
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Ciraolo
authors.forename: Mary B
authors.initials: MB
authors.lastname: Palascak
authors.forename: Clinton H
authors.initials: CH
authors.lastname: Joiner
mesh_terms: D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D002470:Cell Survival; D016922:Cellular Senescence; D003922:Diabetes Mellitus, Type 1 / Q000097:blood*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood*; D004912:Erythrocytes / Q000378:metabolism*; D005260:Female; D006442:Glycated Hemoglobin / Q000378:metabolism*; D006801:Humans; D008297:Male; D008875:Middle Aged
chemical_list: D001786:Blood Glucose; D006442:Glycated Hemoglobin; C517652:hemoglobin A1c protein, human